Date: 2014-07-16
Type of information: Establishment of a new subsidiary in the EU
Company: Oncobiologics (USA - NJ)
Investors: Strides Arcolab (India)
Amount: undisclosed
Funding type:
Planned used:
Others: * On July 16, 2014, Strides Arcolab and Oncobiologics announced that Strides has made a series of strategic investments in Oncobiologics, Inc, a privately held New Jersey biopharmaceutical firm developing a pipeline of biosimilars and next generation biotherapeutics. The investment is part of Strides’ strategy to fund promising biopharma companies with high quality scientific management and proprietary approaches to developments that confer significant time and cost advantages. Financial terms were not disclosed.
Therapeutic area:
